A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV

Central European ◽

Clinical Phase ◽

BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: A phase II study group trial of the central European Society of Anticancer-Drug Research (CESAR)

Investigational New Drugs ◽

10.1007/s10637-005-1445-z ◽

2005 ◽

Vol 23 (4) ◽

pp. 363-368 ◽

Cited By ~ 4

Author(s):

R.-D. Hofheinz ◽

C. Porta ◽

G. Hartung ◽

A. Santoro ◽

A.-R. Hanauske ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Anticancer Drug ◽

Phase Ii ◽

European Society ◽

Drug Research ◽

Phase Ii Study ◽

Study Group ◽

Central European ◽

Group Trial

A Phase II study of the safety, pharmacokinetics and efficacy of IncelTM (biricodar, VX-710) in combination with mitoxantrone (M) and prednisone (P) in advanced hormone refractory prostate cancer (HRPC)

European Journal of Cancer ◽

10.1016/s0959-8049(99)81827-9 ◽

1999 ◽

Vol 35 ◽

pp. S349 ◽

Cited By ~ 1

Author(s):

A. Einstein ◽

R. Lush ◽

R. Rago ◽

G. Bubley ◽

W.D. Henner ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Docetaxel, Vinorelbine, and Zoledronic Acid as First-Line Treatment in Patients with Hormone Refractory Prostate Cancer: A Phase II Study

European Urology ◽

10.1016/j.eururo.2007.02.060 ◽

2007 ◽

Vol 52 (4) ◽

pp. 1020-1027 ◽

Cited By ~ 13

Author(s):

Giuseppe Di Lorenzo ◽

Riccardo Autorino ◽

Sisto Perdonà ◽

Michele De Laurentiis ◽

Massimo D'Armiento ◽

...

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Hormone Refractory ◽

First Line Treatment

A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study

Cancer ◽

10.1002/1097-0142(19930915)72:6<1965::aid-cncr2820720629>3.0.co;2-x ◽

1993 ◽

Vol 72 (6) ◽

pp. 1965-1968 ◽

Cited By ~ 26

Author(s):

Timothy M. Kuzel ◽

Martin S. Tallman ◽

Daniel Shevrin ◽

Edward Braud ◽

Lary Kilton ◽

...

Keyword(s):

Prostate Cancer ◽

Continuous Infusion ◽

Phase Ii ◽

Phase Ii Study ◽

Cancer Center ◽

Hormone Refractory ◽

Center Study

Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)

Investigational New Drugs ◽

10.1023/b:drug.0000047109.76766.84 ◽

2005 ◽

Vol 23 (1) ◽

pp. 79-84 ◽

Cited By ~ 51

Author(s):

Tahir Latif ◽

Laura Wood ◽

Cindy Connell ◽

David C. Smith ◽

David Vaughn ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Phase II Study of Vinorelbine and Low-Dose Docetaxel in Chemotherapy-Naive Patients with Hormone-Refractory Prostate Cancer

The Cancer Journal ◽

10.1097/00130404-200307000-00011 ◽

2003 ◽

Vol 9 (4) ◽

pp. 286-292 ◽

Cited By ~ 14

Author(s):

Alan J. Koletsky ◽

Manuel L. Guerra ◽

Lori Kronish

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Phase II study of vlnorelbine in patients with hormone refractory prostate cancer

European Journal of Cancer ◽

10.1016/s0959-8049(97)84523-6 ◽

1997 ◽

Vol 33 ◽

pp. S33

Author(s):

A. Caty ◽

S. Oudard ◽

Y. Humblet ◽

M. Beauduin ◽

E. Suc ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

899 PUBLICATION A phase II study of sequential chemotherapy with docetaxel-estramustine phosphate (DE) followed by mitoxantrone-prednisone (MP) in patients (pts.) with metastatic hormone refractory prostate cancer (MHRPC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)81194-2 ◽

2005 ◽

Vol 3 (2) ◽

pp. 258

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Estramustine Phosphate ◽

Sequential Chemotherapy ◽

Characterization of Prognostic Factors and Efficacy in a Phase-II Study with Docetaxel and Estramustine for Advanced Hormone Refractory Prostate Cancer

Oncology Research and Treatment ◽

10.1159/000088297 ◽

2005 ◽

Vol 28 (11) ◽

pp. 573-578 ◽

Cited By ~ 5

Author(s):

Thomas Nelius ◽

Frank Reiher ◽

Tobias Lindenmeir ◽

Tobias Klatte ◽

Olrik Rau ◽

...

Keyword(s):

Prostate Cancer ◽

Prognostic Factors ◽

Phase Ii ◽

Phase Ii Study ◽

A phase II study of weekly docetaxel (T), estramustine (E), and celecoxib (C) in patients with hormone refractory prostate cancer (HRPC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4725 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4725-4725 ◽

Cited By ~ 1

Author(s):

B. Mellado ◽

A. Font ◽

J. Carles ◽

G. Catalán ◽

J. L. González Larriba ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Weekly Docetaxel ◽